FTC v Actavis and pricing practices spearhead rise in US pharmaceutical antitrust cases
In summary The past year has continued to see an increase in US case law and other developments in the area of pharmaceutical antitrust. This article examines antitrust claims under the US Supreme Court’s decision in FTC v Actavis for settlements of patent …